Combining IFN-γ with MSC Therapy Yields Better Results in RA Patients
A randomized controlled trial suggests that interferon-gamma (IFN-γ) plays a critical role in improving the effectiveness of mesenchymal stem cell therapy in individuals with rheumatoid arthritis.
